Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
2(50.0%)
4Total
Phase 2(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02486042Phase 2Completed

Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity

Role: collaborator

NCT02582164Not ApplicableCompleted

Long-Working Distance OCT for Children

Role: collaborator

NCT03741322Completed

A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness

Role: collaborator

NCT02572973Not ApplicableTerminated

Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders

Role: collaborator

NCT02445417Completed

Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury

Role: collaborator

NCT01328496Phase 2Completed

Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

Role: collaborator

All 6 trials loaded